China issues new rules to prevent monopolies in online pharmaceuticals, targeting data misuse and "product hopping."

China's State Council issued new guidelines to prevent monopolistic practices in the pharmaceutical industry, focusing on online medicine businesses and prohibiting the misuse of data and algorithms. The guidelines also target "product hopping," where drug makers avoid competition from generics. These detailed regulations aim to foster fair competition and protect consumers.

2 months ago
3 Articles

Further Reading